A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

February 6, 2024

Study Completion Date

March 5, 2024

Conditions
Treatment Resistant Depression
Interventions
DRUG

Liafensine

Liafensine

DRUG

Placebo

Placebo

Trial Locations (45)

11004

Zucker Hillside Hospital, Glen Oaks

18104

Lehigh Center for Clinical Research, LLC, Allentown

18507

Global Medical Institutes, LLC, Moosic

20877

CBH Health LLC, Gaithersburg

21208

Pharmasite Research, Inc., Baltimore

30060

Psych Atlanta, PC, Marietta

30331

CenExel Atlanta Center for Medical Research, Atlanta

32801

Clinical Neuroscience Solutions, Inc., Orlando

33121

The Medicine Medical Research, Hollywood

33145

Nuovida Research Center, Miami

SG Research, LLC, Miami

33511

Clinical Research of Brandon, LLC, Brandon

34105

Aqualane Clinical Research, Naples

34613

Access Research Institute, Brooksville

35801

University of Alabama at Birmingham, Huntsville

43210

The Ohio State University Department of Psychiatry, Columbus

48302

Neurobehavioral Medicine Group, Bloomfield

60123

Revive Research Institute, Inc, Elgin

67214

Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc., Wichita

68526

Alivation Research, LLC, Lincoln

75115

InSite Clinical Research, DeSoto

75231

FutureSearch Trials of Dallas, Dallas

76014

North Texas Clinical Trials, Fort Worth

77054

University of Texas Medical School at Houston, Houston

85012

Alea Research, Phoenix

87109

IMA Clinical Research, Albuquerque

89102

Altea Research Institute, Las Vegas, Las Vegas

90502

Collaborative Neuroscience Research, LLC, Torrance

91206

Behavioral Research Specialists, LLC, Glendale

91403

Schuster Medical Research Institute, Sherman Oaks

91786

Pacific Clinical Research Management Group, Upland

92056

Excell Research, Oceanside

92374

Anderson Clinical Reseach, Redlands

92845

Collaborative Neuroschience Research, LLC, Garden Grove

94549

Sunwise Clinical Research, LLC., Lafayette

98201

Core Clinical Research, Everett

02131

Boston Clinical Trials & Medical Research, Boston

08053

Hassman Research Institute, Marlton

08510

Global Medical Institutes, LLC, Princeton

08540

Global Medical Institutes, LLC, Princeton

08755

Bio Behavior Health, Toms River

V1Y 1Z9

OCT Research ULC, Kelowna

L3R 1A3

AMNDX Inc., Markham

M5B1M4

St. Michael's Hospital, Toronto

M5T 1R8

CAMH-Russell Street Site 250 College Street, Toronto

Sponsors
All Listed Sponsors
lead

Denovo Biopharma LLC

INDUSTRY

NCT05113771 - A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD | Biotech Hunter | Biotech Hunter